Close
  • All
  • Centres
  • Courses
  • Events
  • News
  • People
  • Projects

Dr Kwabena Asare

Research Fellow

London School of Hygiene & Tropical Medicine
Keppel street
London
United Kingdom

Kwabena is an Epidemiologist at the Department of Non-Communicable Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine. He works with the Brain Health study group under the Electronic Health Records group. His current reserach with Professor Charlotte Warren-Gash includes studies related to infections, brain health and frailty during old age in the Clinical Practice Research Database in the UK and the Veterans Administration in the US. His research interests include using robust causal inference methodology to estimate causal effects of interventions and exposures from observational data to inform Public Health decision making. 

 

He holds a PhD in Public Health from University of KwaZulu-Natal, Durban, South Africa. His PhD research focused on contributing evidence to inform targeted interventions and healthcare policy to improve STI care in limited resource and HIV endemic settings in Sub-Saharan Africa. 

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

I teach on intensive, distance learning and short course modules in Epidemiology, Medical Statistics, Sexual and Reproductive Health Policy, Electronic Health Records Research and Pharmacoepidemiology. 

Research

Research Area
Epidemiology
Electronic health records
Disease and Health Conditions
Non-communicable diseases
Mental health
HIV/AIDS
Sexually transmitted infections
Chronic diseases
Infectious diseases
Country
United Kingdom

Selected Publications

Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Ngwenya, T; Ntokozo, MS; Lessells, R; Naidoo, K; Sosibo, P; BOTTOMLEY, C; Garrett, N; Dorward, J;
2024
medRxiv
Risk of major adverse cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: emulated target trials using routine, de-identified data from South Africa
Dorward, J; Masombuka, X; Lewis, L; Pastellides, C; Van der Molen, J; ASARE, K; Tlhaku, K; Brown, JA; BOTTOMLEY, C; Jacobs, D; Collie, S; Garrett, N;
2025
Cold Spring Harbor Laboratory
Retrospective cohort analysis of antiretroviral therapy initiation timelines and clinical outcomes in adults with HIV and TB disease in KwaZulu-Natal, South Africa
Jansen van Vuuren, CJ; Van der Molen, J; Sookrajh, Y; Ngwenya, T; Khubone, T; Mkhize, S; ASARE, K; Naidoo, K; Lessells, R; Lewis, L; Garrett, N; Dorward, J;
2025
Cold Spring Harbor Laboratory
Determinants of glycemic control among persons living with type 2 diabetes mellitus attending a district hospital in Ghana.
Adjei, A; Brightson, KT C; Mensah, MM; Osei, J; Drah, M; Narh, CT; ASARE, K; Anto, F;
2024
PloS one
Impact of increasing CD4 count threshold eligibility for antiretroviral therapy initiation on advanced HIV disease and tuberculosis prevalence and incidence in South Africa: an interrupted time series analysis
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Ngwenya, T; Ntokozo, MS; Lessells, R; Naidoo, K; Sosibo, P; BOTTOMLEY, C; Garrett, N; Dorward, J;
2024
medRxiv
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.
ASARE, K; Sookrajh, Y; Van der Molen, J; Khubone, T; Lewis, L; Lessells, RJ; Naidoo, K; Sosibo, P; Van Heerden, R; Garrett, N; Dorward, J;
2023
The Lancet Global health
Relationship between physical activity and behaviour challenges of adolescents in South Africa.
ASARE, K; Ntlantsana, V; Ranjit, K; Tomita, A; Paruk, S;
2023
The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.
ASARE, K; Lewis, L; Van der Molen, J; Sookrajh, Y; Khubone, T; Moodley, P; Lessells, RJ; Naidoo, K; Sosibo, P; Garrett, N; Dorward, J;
2023
Open forum infectious diseases
See more information